Announcements Trials
Browse Landscape

Phase

Phase 3 12Phase 2 6Phase 4 3Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 27Vincristine 24Dexamethasone 22Rituximab 21Methotrexate 21Cytarabine 21Mercaptopurine 16Doxorubicin 15Etoposide 13Asparaginase 13Daunorubicin 12Prednisone 10Prednisolone 10Granulocyte Colony-Stimulating Factor 10Ifosfamide 8Idarubicin 8fludarabine 7pegylated granulocyte colony-stimulating factor 6Thioguanine 6Teniposide 6Vindesine 5Brentuximab Vedotin 5ibrutinib 4fludarabine phosphate 4Stem Cell Transplantation 4Gemcitabine 4Cisplatin 4Aprepitant 4zanubrutinib 3prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × VAP-cyclo protocol × Lymphoid × Clear all
NCT03631862 2018-08-15

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Zhengzhou University

Phase 4 Unknown
100 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT01664975 2016-10-05

Treatment of Peripheral T-cell Lymphoma

Zhengzhou University

Phase 4 Completed
100 enrolled 7 charts
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT01949818 2015-12-30

Treatment of Diffuse Large B Cell Lymphoma

Zhengzhou University

Phase 4 Unknown
120 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡